Press Release
Home > Press Release > PR Newswire
Roxane Laboratories, Inc. Announces the Launch of Calcium Acetate Capsules, 667mg
COLUMBUS, Ohio, Oct. 15 /PRNewswire/ -- Roxane Laboratories, Inc.announced today the approval of its Abbreviated New Drug Application (ANDA)for Calcium Acetate Capsules, 667mg by the U.S. Food and Drug Administration.The product is available in bottles of 200 capsules for immediate shipment towholesalers and pharmacies nationwide.
(Logo: http://www.newscom.com/cgi-bin/prnh/20070410/CLTU122LOGO )
Roxane Laboratories' Calcium Acetate Capsules, 667mg are AB rated toPhosLo(R) (calcium acetate) capsules. Annual sales of Calcium AcetateCapsules, 667mg are approximately $84.8 Million(1).
Full prescribing information for Calcium Acetate Capsules, 667mg isavailable on the Roxane Laboratories website at www.Roxane.com or upon requestby calling Roxane Laboratories Technical Product Information at1.800.962.8364.
About Roxane Laboratories, Inc.
Roxane Laboratories is located in Columbus, OH in a modern 500,000 squarefoot manufacturing and laboratory facility. The facility spans 70 acres andcurrently employs over 1,000 people. Currently, Roxane Laboratories marketsover 75 medications in nearly 250 package sizes, focusing on an expanding lineof Multisource pharmaceutical products including: bulk and unit-dose liquidsand solids; coated, sustained-release and controlled-release tablets; nasalsprays, cytotoxics and CII narcotics.
Roxane Laboratories, Inc., is a subsidiary of Boehringer IngelheimCorporation, based in Ridgefield, CT and a member of the Boehringer Ingelheimgroup of companies.
About Boehringer Ingelheim
Boehringer Ingelheim Corporation based in Ridgefield, CT, is the USheadquarters to seven subsidiaries and a member of the Boehringer Ingelheimgroup of companies.
The Boehringer Ingelheim group is one of the world's 20 leadingpharmaceutical companies. Headquartered in Ingelheim, Germany, it operatesglobally with 135 affiliates in 47 countries and approximately 39,800employees. Since it was founded in 1885, the family-owned company has beencommitted to researching, developing, manufacturing and marketing novelproducts of high therapeutic value for human and veterinary medicine.
In 2007, Boehringer Ingelheim posted net sales of US $15.0 billion (10.9billion euro) while spending approximately one-fifth of net sales in itslargest business segment, Prescription Medicines, on research and development.
For more information on Boehringer Ingelheim, please visithttp://us.boehringer-ingelheim.com .
(1) IMS MAT dollar sales ending 6/2008
PhosLo(R) is a registered trademark of Fresenius Medical Care.
SOURCE Roxane Laboratories, Inc.
Roxane Laboratories' Calcium Acetate Capsules, 667mg are AB rated toPhosLo(R) (calcium acetate) capsules. Annual sales of Calcium AcetateCapsules, 667mg are approximately $84.8 Million(1).
Full prescribing information for Calcium Acetate Capsules, 667mg isavailable on the Roxane Laboratories website at www.Roxane.com or upon requestby calling Roxane Laboratories Technical Product Information at1.800.962.8364.
About Roxane Laboratories, Inc.
Roxane Laboratories is located in Columbus, OH in a modern 500,000 squarefoot manufacturing and laboratory facility. The facility spans 70 acres andcurrently employs over 1,000 people. Currently, Roxane Laboratories marketsover 75 medications in nearly 250 package sizes, focusing on an expanding lineof Multisource pharmaceutical products including: bulk and unit-dose liquidsand solids; coated, sustained-release and controlled-release tablets; nasalsprays, cytotoxics and CII narcotics.
Roxane Laboratories, Inc., is a subsidiary of Boehringer IngelheimCorporation, based in Ridgefield, CT and a member of the Boehringer Ingelheimgroup of companies.
About Boehringer Ingelheim
Boehringer Ingelheim Corporation based in Ridgefield, CT, is the USheadquarters to seven subsidiaries and a member of the Boehringer Ingelheimgroup of companies.
The Boehringer Ingelheim group is one of the world's 20 leadingpharmaceutical companies. Headquartered in Ingelheim, Germany, it operatesglobally with 135 affiliates in 47 countries and approximately 39,800employees. Since it was founded in 1885, the family-owned company has beencommitted to researching, developing, manufacturing and marketing novelproducts of high therapeutic value for human and veterinary medicine.
In 2007, Boehringer Ingelheim posted net sales of US $15.0 billion (10.9billion euro) while spending approximately one-fifth of net sales in itslargest business segment, Prescription Medicines, on research and development.
For more information on Boehringer Ingelheim, please visithttp://us.boehringer-ingelheim.com .
(1) IMS MAT dollar sales ending 6/2008
PhosLo(R) is a registered trademark of Fresenius Medical Care.
SOURCE Roxane Laboratories, Inc.
For more iinformation, go to www.prnewswire.com
Recent Press Release
- 1 Digital Photo Frame Market Will Get Connected
- 2 Priceless Legacy Company Appoints Julie Davis to Legacy Consultant Position in Nebraska and Iowa
- 3 Koko the Gorilla Celebrates 38th Birthday, Makes Three Wishes
- 4 New Website Provides A Free List Of The Top Ten Chicago Real Estate Deals
- 5 Warrior Custom Golf Assists the Orange County United Way 2009 Fundraising Campaign
- 6 Kerching Online Casino Competition Winner Revealed
- 7 MyFirePits.com Announces Grand Opening
Advertisement
Option Trading Was Never So Easy
Come and experience the trading platform that everyone talks about. Simple, fast and exciting.
Press Release Distribution - IBwire
Effective and Affordable Press Release Distribution Service
Forex trading is too complicated?
Can predict currency pairs movements? Binary option trading is what you need. Click here.









